A study of the relationship between the proportional insulin glargine evening dose and the perioperative serum glucose values in patients with diabetes undergoing surgery.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2012
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Mar 2012 Actual number of patients changed from 267 to 402 as reported by ClinicalTrials.gov.
- 22 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2008 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History